MENU
Home
Add Document
Sign In
Create An Account
PDF Reader
Full Text
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
NII-Electronic Library Service
Suggest Documents
Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity.
Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
Muramyl dipeptide improves mononuclear phagocyte system function in obstructive jaundice.
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins.
Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.
Increased expression of alkaline phosphatase activity in stimulated B lymphocytes by muramyl dipeptide.
The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.
Novel 2,4-dianilino-5-fluoropyrimidine derivatives possessing ALK inhibitory activities.
Pharmacokinetic profile of the immunomodulating compound adamantylamide dipeptide (AdDP), a muramyl dipeptide derivative in mice.
Antitumor activity of derivatives of mycophenolic acid.
Lipophilic Muramyl Dipeptide-Antigen Conjugates as Immunostimulating Agents.
Granuloma formation by synthetic bacterial cell wall fragment: muramyl dipeptide.
Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy.
Functional properties of a novel hybrid antimicrobial peptide NS: potent antitumor activity and efficient plasmid delivery.
Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.
Synthesis and antitumor activity of novel per-butyrylated glycosides of podophyllotoxin and its derivatives.
Discovery of novel antitumor dibenzocyclooctatetraene derivatives and related biphenyls as potent inhibitors of NF-κB signaling pathway.
Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.
NII-Electronic Library Service NII-Electronic Library Service NII-Electronic Library Service NII-Electronic Library Service...
493KB Sizes
0 Downloads
0 Views
Download PDF
Recommend Documents
Novel arabinofuranosyl derivatives of cytosine resistant to enzymatic deamination and possessing potent antitumor activity.
Combined effects of synthetic lipid A analogs and muramyl dipeptide on antitumor activity against Meth A fibrosarcoma in mice.
Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
Stimulation of the reticuloendothelial system of mice by muramyl dipeptide.
Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity.
Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
Novel derivatives of 5-fluorouridine and 5-fluorouracil having potent antitumor and lower immunosuppressive activities.
Muramyl dipeptide improves mononuclear phagocyte system function in obstructive jaundice.
Synthesis and biological evaluation of diarylthiazole derivatives as antimitotic and antivascular agents with potent antitumor activity.
New potent mitomycin derivatives: synthesis and antitumor activity of 7,7-(ethylenedioxy)mitomycins.
×
Sign In
Login with Facebook
Don't have an account?
Forgot Password?
×
Sign Up
By clicking register, I agree to your terms